Budget

Critics say NIH stung by budget proposal

Advocates say the National Institutes of Health is working with 22% less buying power than it had 11 years ago.

Business briefs: AbbVie, FDA, and health spending projections

AbbVie and Galapagos go after cystic fibrosis; FDA's NME approval pace slows; government shutdown could slow ad-com votes; and a report shows privately insured patients had emptier pockets in 2012 than 2011

Sequester cuts could snarl approvals for years

Sequester cuts could snarl approvals for years

By

With sequester cuts taking effect and no sign of a deal to end them in sight, FDA stands to lose 5% of its 2013 budget—though coming five months into the Federal fiscal year, it will feel more like 9%—and while the agency has said it has no plans at present for layoffs, it's certain the approvals process will slow as the agency absorbs the loss.

Pharma finds happy medium in 90-sec. TV spot

Pharma finds happy medium in 90-sec. TV spot

By

The advent of new ad-unit lengths is bringing drugmakers much-needed relief from the high cost of advertising on television.

Marketing-research budgets on the mend, survey suggests

By

An analysis of a cross-section of the pharma industry shows budgets of pharmaceutical marketing research teams are starting to recover from 2008 lows.

Pfizer, Crestor tops for global promotional spend in 2011

Pfizer, Crestor tops for global promotional spend in 2011

By

Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.

President's budget would deal a wallop to biopharma wallets

President's budget would deal a wallop to biopharma wallets

By

President Obama's proposed 2013 budget would mandate an estimated $156 billion in new rebates to low-income seniors through Medicare over the next decade - discounts that would come out of the pockets of drug companies and could cost tens of thousands of jobs, according to PhRMA.

DTC spending stabilized in 2009 amid strong growth for cable, Internet adspend

By

Pharma spending on consumer advertising was largely flat in 2009, rising 1.9% to $4.5 billion over 2008 spend, according to data from The Nielsen Company. That's good news for media companies, suggesting that spending has hit bottom following two years of steep declines.

Making Marketing Dollars Count: Made to Measure

In an age of accountability, where every dollar counts, Deborah Dick-Rath talks to industry insiders about how they can make a measurable difference in their marketing mix

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.